GGNBP1, gametogenetin binding protein 1 (pseudogene), 449520
N. diseases: 21; N. variants: 20
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phenotype | Laboratory Procedure | 265 | 457 | 0.100 | None | 1.000 | 12 | 11 | 2009 | 2019 | |||||
|
disease | Neoplasms; Male Urogenital Diseases; Endocrine System Diseases | Neoplastic Process | 208 | 93 | 0.100 | None | 1.000 | 5 | 1 | 2009 | 2017 | ||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 1447 | 291 | 0.100 | None | 1.000 | 4 | 3 | 2012 | 2017 | ||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 120 | 122 | 0.100 | None | 1.000 | 4 | 2 | 2012 | 2017 | ||||
|
group | Neoplasms; Male Urogenital Diseases; Endocrine System Diseases | Neoplastic Process | 124 | 31 | 0.100 | None | 1.000 | 3 | 1 | 2009 | 2013 | ||||
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 2872 | 2897 | 0.100 | None | 1.000 | 3 | 2 | 2015 | 2019 | ||||
|
phenotype | Laboratory Procedure | 610 | 1144 | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | |||||
|
phenotype | Laboratory Procedure | 283 | 679 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
disease | Neoplasms; Male Urogenital Diseases; Endocrine System Diseases | Neoplastic Process | 128 | 62 | 0.100 | None | 1.000 | 1 | 3 | 2010 | 2010 | ||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 545 | 1440 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 223 | 371 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 272 | 452 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
group | Mental Disorders | Mental or Behavioral Dysfunction | 168 | 379 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
disease | Immune System Diseases; Nervous System Diseases | Disease or Syndrome | 1800 | 1022 | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | Neoplastic Process | 1740 | 865 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
phenotype | Laboratory Procedure | 681 | 1322 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 900 | 148 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
disease | Digestive System Diseases; Infections | Disease or Syndrome | 1449 | 519 | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||
|
disease | Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | Neoplastic Process | 1553 | 320 | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 |